Cabio Biotech (Wuhan) Market Cap

Cabio Biotech (Wuhan) has a market cap or net worth of 4.33 billion as of May 7, 2025. Its market cap has increased by 69.34% in one year.

Market Cap

4.33B

Enterprise Value

4.19B

Revenue

594.54M

Ranking

n/a

PE Ratio

29.51

Stock Price

25.85

Market Cap Chart

Since December 19, 2019, Cabio Biotech (Wuhan)'s market cap has decreased from 5.54B to 4.33B, a decrease of -21.81%. That is a compound annual growth rate of -4.46%.

Market Cap History

Date	Market Cap	% Change
May 7, 2025	4.33B	35.26%
Dec 31, 2024	3.20B	6.31%
Dec 29, 2023	3.01B	-44.60%
Dec 30, 2022	5.44B	-26.24%
Dec 31, 2021	7.37B	55.15%
Dec 31, 2020	4.75B	6.39%
Dec 31, 2019	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Jiangsu Hengrui Medicine	324.29B
Shenzhen Mindray Bio-Medical Electronics	266.36B
WuXi AppTec	171.99B
Zhangzhou Pientzehuang Pharmaceutical.,	123.88B
Aier Eye Hospital Group	122.82B
Sichuan Biokin Pharmaceutical	114.72B
Shanghai United Imaging Healthcare	110.09B
Yunnan Baiyao Group Co.,Ltd	101.33B

Market Cap Rankings